Literature DB >> 8481522

Sickle erythrocyte-endothelial interactions in microcirculation: the role of von Willebrand factor and implications for vasoocclusion.

D K Kaul1, R L Nagel, D Chen, H M Tsai.   

Abstract

To determine the role of von Willebrand factor (vWF) in adhesion of sickle (SS) erythrocytes in microvascular flow conditions, we have perfused the ex vivo mesocecum vasculature of the rat with desmopressin, an analogue of vasopressin that causes the release of endothelial vWF. Analysis of vWF in the venous effluent of the isolated vasculature showed mainly the presence of extra-large molecular weight forms characteristic of endothelial vWF, which in the presence of desmopressin showed an average increase of 54%. Also, desmopressin induced a significant increase in adhesion of washed oxygenated (oxy) unseparated SS erythrocytes, accompanied by a persistent microvascular obstruction and a pronounced increase in the peripheral resistance (PRU). In contrast, infusion of SS deformable discocytes (SS2) in desmopressin-perfused vasculature resulted in a significant adhesion but not in persistent vasoocclusion, showing that SS2 discocytes alone are not sufficient for microvascular obstruction. Furthermore, SS4 erythrocytes (dense discocytes and irreversibly sickled erythrocytes) caused a persistent microvascular blockage and a significantly higher PRU than SS2 discocytes. However, the increase in PRU for SS4 erythrocytes following desmopressin treatment was 50% less compared with a corresponding increase for SS2 discocytes over the control values, which showed a smaller effect of desmopressin on the hemodynamic behavior of SS4 dense erythrocytes. Incubation of desmopressin-treated vasculature with anti-vWF antibodies resulted in a pronounced decrease in adhesion and significantly improved hemodynamic behavior of SS cells. Also, in untreated vasculature, similarly incubated with anti-vWF antibodies, there was almost complete inhibition of adhesion. Under the described perfusion conditions, antibodies to fibronectin and thrombospondin, as well as incubation of SS erythrocytes with anti-vWF antibodies did not affect adhesion. These results are compatible with a model for SS vasoocclusion in which extra-large vWF-mediated adhesion of deformable SS erythrocytes is the first step followed by an accelerated entrapment of dense SS erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8481522

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

Review 1.  Sickle cell disease: old discoveries, new concepts, and future promise.

Authors:  Paul S Frenette; George F Atweh
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

Review 2.  Redox-dependent impairment of vascular function in sickle cell disease.

Authors:  Mutay Aslan; Bruce A Freeman
Journal:  Free Radic Biol Med       Date:  2007-08-31       Impact factor: 7.376

3.  Why Do We Need ADAMTS13?

Authors:  Han-Mou Tsai
Journal:  Nihon Kessen Shiketsu Gakkai shi       Date:  2005

4.  Brain venular pattern by 7T MRI correlates with memory and haemoglobin in sickle cell anaemia.

Authors:  Enrico M Novelli; C Elizabeth Sarles; Howard Jay Aizenstein; Tamer S Ibrahim; Meryl A Butters; Anne Connelly Ritter; Kirk I Erickson; Caterina Rosano
Journal:  Psychiatry Res       Date:  2015-04-25       Impact factor: 3.222

5.  N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice.

Authors:  Junmei Chen; Adili Reheman; Francisca C Gushiken; Leticia Nolasco; Xiaoyun Fu; Joel L Moake; Heyu Ni; José A López
Journal:  J Clin Invest       Date:  2011-01-25       Impact factor: 14.808

6.  Differential modulation of adhesion molecule expression by hydroxycarbamide in human endothelial cells from the micro- and macrocirculation: potential implications in sickle cell disease vasoocclusive events.

Authors:  Sandrine Laurance; Pauline Lansiaux; François-Xavier Pellay; Michelle Hauchecorne; Arndt Benecke; Jacques Elion; Claudine Lapoumeroulie
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

7.  Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication.

Authors:  Rakhi P Naik; Michael B Streiff; Carlton Haywood; Julie A Nelson; Sophie Lanzkron
Journal:  Am J Med       Date:  2013-05       Impact factor: 4.965

8.  Increased von Willebrand factor antigen and high molecular weight multimers in sickle cell disease associated with nocturnal hypoxemia.

Authors:  Suba Krishnan; Jamie Siegel; Gene Pullen; Megan Hevelow; Carlton Dampier; Marie Stuart
Journal:  Thromb Res       Date:  2008-01-29       Impact factor: 3.944

9.  Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.

Authors:  Anwar Al-Awadhi; Adekunle Adekile; Rajaa Marouf
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

10.  Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension.

Authors:  Natasha M Rogers; Mingyi Yao; John Sembrat; M Patricia George; Heather Knupp; Mark Ross; Maryam Sharifi-Sanjani; Jadranka Milosevic; Claudette St Croix; Revathi Rajkumar; Maria G Frid; Kendall S Hunter; Luciano Mazzaro; Enrico M Novelli; Kurt R Stenmark; Mark T Gladwin; Ferhaan Ahmad; Hunter C Champion; Jeffrey S Isenberg
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.